Nature Rev Immunol Profile Banner
Nature Rev Immunol Profile
Nature Rev Immunol

@NatRevImmunol

68,766
Followers
1,014
Following
978
Media
6,226
Statuses

We publish immunology reviews and highlight exciting new research papers. Tweets from the editors: Alex, Kirsty, Lucy & Yvonne.

London, UK
Joined February 2011
Don't wanna be here? Send us removal request.
Pinned Tweet
@NatRevImmunol
Nature Rev Immunol
8 days
You can now request a free copy of the poster from our sponsor @STEMCELLTech using the following link:
@NatRevImmunol
Nature Rev Immunol
1 month
Rational combination of cancer therapies with PD1 axis blockade New poster by @d_peeper & @ThommenDaniela with our pals @NatureRevCancer looking at how therapies can be combined in a rational manner to provide cooperative or synergistic benefit
Tweet media one
0
8
61
0
0
7
@NatRevImmunol
Nature Rev Immunol
26 days
Mechanisms of antibody-dependent enhancement of infectious disease
Tweet media one
1
84
247
@NatRevImmunol
Nature Rev Immunol
4 years
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Tweet media one
8
528
940
@NatRevImmunol
Nature Rev Immunol
2 years
The roles of extracellular vesicles in the immune system
Tweet media one
3
211
771
@NatRevImmunol
Nature Rev Immunol
4 years
The trinity of COVID-19: immunity, inflammation and intervention
Tweet media one
3
413
724
@NatRevImmunol
Nature Rev Immunol
3 years
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Tweet media one
7
255
670
@NatRevImmunol
Nature Rev Immunol
2 years
NEW Review: The roles of extracellular vesicles in the immune system by @EditBuzas @semmelweishu including roles of #EVs in innate and adaptive immunity, and potential use for diagnosis and therapy #extracellularvesicles #exosomes
Tweet media one
4
189
622
@NatRevImmunol
Nature Rev Immunol
1 month
Location matters: mapping antigen receptors within tissues
Tweet media one
0
70
283
@NatRevImmunol
Nature Rev Immunol
3 years
Natural killer cells in antiviral immunity
Tweet media one
3
173
532
@NatRevImmunol
Nature Rev Immunol
4 years
'A guide to vaccinology: from basic principles to new developments' Andrew Pollard & Else Bijker @UniofOxford @OxfordVacGroup "an introductory overview of vaccines, immunization and related issues to inform a broad scientific audience" #VaccinesWork
Tweet media one
2
248
483
@NatRevImmunol
Nature Rev Immunol
4 years
Complement as a target in COVID-19?
Tweet media one
4
268
467
@NatRevImmunol
Nature Rev Immunol
3 years
Engineering IL-2 for immunotherapy of autoimmunity and cancer
Tweet media one
3
90
456
@NatRevImmunol
Nature Rev Immunol
11 months
The effect of physical exercise on anticancer immunity
Tweet media one
1
175
464
@NatRevImmunol
Nature Rev Immunol
3 years
Fibroblasts as immune regulators in infection, inflammation and cancer
Tweet media one
3
121
451
@NatRevImmunol
Nature Rev Immunol
2 years
Immunomodulation by endothelial cells — partnering up with the immune system?
Tweet media one
5
127
442
@NatRevImmunol
Nature Rev Immunol
7 months
New immune cell engagers for cancer immunotherapy
Tweet media one
1
143
434
@NatRevImmunol
Nature Rev Immunol
3 months
Ultra-processed foods: increasing the risk of inflammation and immune dysregulation?
Tweet media one
2
150
426
@NatRevImmunol
Nature Rev Immunol
4 years
COVID-19 vaccines: modes of immune activation and future challenges
Tweet media one
3
163
409
@NatRevImmunol
Nature Rev Immunol
6 months
The OrganiX microfluidic system to recreate the complex tumour microenvironment
Tweet media one
1
91
367
@NatRevImmunol
Nature Rev Immunol
1 year
New: Our current understanding of the immunology behind #LongCovid , a comprehensive Review by @Daltmann10 , Emily M. Whetlock, Siyi Liu, Deepa J. Arachchillage and @BoytonRosemary
Tweet media one
8
197
384
@NatRevImmunol
Nature Rev Immunol
1 month
Rational combination of cancer therapies with PD1 axis blockade New poster by @d_peeper & @ThommenDaniela with our pals @NatureRevCancer looking at how therapies can be combined in a rational manner to provide cooperative or synergistic benefit
Tweet media one
0
8
61
@NatRevImmunol
Nature Rev Immunol
3 months
NEW Review: A guide to adaptive immune memory by @DonnaFarber3 @noralam_ & YoonSeung Lee provides an overview of current understanding of the phenotype, function, location, generation, maintenance and protective capacity of memory T cells and B cells
Tweet media one
0
108
383
@NatRevImmunol
Nature Rev Immunol
3 years
How the immune system shapes atherosclerosis: roles of innate and adaptive immunity
Tweet media one
1
100
368
@NatRevImmunol
Nature Rev Immunol
7 months
Mechanistic insights from inflammasome structures
Tweet media one
2
93
372
@NatRevImmunol
Nature Rev Immunol
3 years
The type I interferonopathies: 10 years on
Tweet media one
1
107
365
@NatRevImmunol
Nature Rev Immunol
9 months
Same yet different — how lymph node heterogeneity affects immune responses
Tweet media one
0
105
332
@NatRevImmunol
Nature Rev Immunol
3 years
'The first 12 months of COVID-19: a timeline of immunological insights' by @VirusesImmunity @florian_krammer @CyrilPedia details the collaborative efforts that enabled key aspects of the immune response to SARS-CoV-2 to be reported at unprecedented speed
Tweet media one
5
137
333
@NatRevImmunol
Nature Rev Immunol
6 years
Congratulations to James Allison and Tasuku Honjo #NobelPrize #cancer #immunotherapy Watch our movie (with @NatureRevCancer ) to learn how immune checkpoint therapy works:
Tweet media one
2
198
323
@NatRevImmunol
Nature Rev Immunol
2 years
TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective
Tweet media one
1
84
330
@NatRevImmunol
Nature Rev Immunol
3 years
The germinal centre B cell response to SARS-CoV-2
Tweet media one
4
117
324
@NatRevImmunol
Nature Rev Immunol
2 months
How bile acids and the microbiota interact to shape host immunity
Tweet media one
1
97
327
@NatRevImmunol
Nature Rev Immunol
4 years
Dissecting antibody-mediated protection against SARS-CoV-2
Tweet media one
4
172
320
@NatRevImmunol
Nature Rev Immunol
2 years
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Tweet media one
3
97
320
@NatRevImmunol
Nature Rev Immunol
3 years
Inflammasome activation at the crux of severe COVID-19
Tweet media one
3
107
302
@NatRevImmunol
Nature Rev Immunol
3 years
CD8+ T cell differentiation and dysfunction in cancer
Tweet media one
0
74
301
@NatRevImmunol
Nature Rev Immunol
1 year
A guide to thymic selection of T cells
Tweet media one
1
82
308
@NatRevImmunol
Nature Rev Immunol
4 years
The potential danger of suboptimal antibody responses in COVID-19
Tweet media one
3
167
297
@NatRevImmunol
Nature Rev Immunol
4 years
Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey
Tweet media one
0
95
297
@NatRevImmunol
Nature Rev Immunol
4 years
Regulation of immune responses by the airway epithelial cell landscape
Tweet media one
0
84
293
@NatRevImmunol
Nature Rev Immunol
3 years
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
Tweet media one
1
95
294
@NatRevImmunol
Nature Rev Immunol
3 years
Inflammation and immune dysfunction in Parkinson disease
Tweet media one
6
104
280
@NatRevImmunol
Nature Rev Immunol
5 months
Cancer cell metabolism and antitumour immunity
Tweet media one
5
90
280
@NatRevImmunol
Nature Rev Immunol
4 years
Human stem cell models to study host–virus interactions in the central nervous system
Tweet media one
1
66
265
@NatRevImmunol
Nature Rev Immunol
3 years
The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
Tweet media one
1
134
271
@NatRevImmunol
Nature Rev Immunol
4 years
mRNA vaccine shows promise in autoimmunity
Tweet media one
5
72
265
@NatRevImmunol
Nature Rev Immunol
4 years
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
Tweet media one
1
75
266
@NatRevImmunol
Nature Rev Immunol
4 years
New Comment article from @VirusesImmunity and Yexin Yang on the potential danger of suboptimal antibody responses in COVID-19
4
151
264
@NatRevImmunol
Nature Rev Immunol
4 years
Viral targets for vaccines against COVID-19
Tweet media one
0
87
262
@NatRevImmunol
Nature Rev Immunol
4 years
NEW Comment article by @VikiLovesFACS @imperialcollege 'Are COVID-19 vaccines safe in pregnancy?'
Tweet media one
4
118
262
@NatRevImmunol
Nature Rev Immunol
3 years
Mucosal vaccines — fortifying the frontiers
Tweet media one
3
103
256
@NatRevImmunol
Nature Rev Immunol
1 year
Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodies
Tweet media one
0
80
260
@NatRevImmunol
Nature Rev Immunol
7 months
The immunology of type 1 diabetes
Tweet media one
1
85
261
@NatRevImmunol
Nature Rev Immunol
4 years
T cell regeneration after immunological injury
Tweet media one
0
84
254
@NatRevImmunol
Nature Rev Immunol
2 years
Mitochondrial control of inflammation
Tweet media one
4
70
258
@NatRevImmunol
Nature Rev Immunol
7 months
The conneXion between sex and immune responses
Tweet media one
1
96
255
@NatRevImmunol
Nature Rev Immunol
2 years
Bacterial origins of human cell-autonomous innate immune mechanisms
Tweet media one
0
70
248
@NatRevImmunol
Nature Rev Immunol
2 years
The role of platelets in immune-mediated inflammatory diseases
Tweet media one
1
70
245
@NatRevImmunol
Nature Rev Immunol
1 year
Memory B cells
Tweet media one
1
80
243
@NatRevImmunol
Nature Rev Immunol
10 months
Role of the microbiota in response to and recovery from cancer therapy
Tweet media one
0
105
241
@NatRevImmunol
Nature Rev Immunol
6 years
New Review on how circadian rhythms influence the immune system. #circadian_clock #chrono -immunotherapy
Tweet media one
1
167
231
@NatRevImmunol
Nature Rev Immunol
2 years
Glomerulonephritis: immunopathogenesis and immunotherapy
Tweet media one
1
70
237
@NatRevImmunol
Nature Rev Immunol
3 years
The precursors of CD8+ tissue resident memory T cells: from lymphoid organs to infected tissues
Tweet media one
1
65
235
@NatRevImmunol
Nature Rev Immunol
4 years
See new Progress article from Zeyu Chen and @EJohnWherry on T cell responses in patients with COVID-19
Tweet media one
2
124
230
@NatRevImmunol
Nature Rev Immunol
3 years
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Tweet media one
0
59
228
@NatRevImmunol
Nature Rev Immunol
3 years
A guide to interrogating immunometabolism
Tweet media one
2
62
228
@NatRevImmunol
Nature Rev Immunol
3 years
Red blood cells join the ranks as immune sentinels
Tweet media one
4
81
224
@NatRevImmunol
Nature Rev Immunol
2 years
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Tweet media one
0
67
219
@NatRevImmunol
Nature Rev Immunol
2 years
Tumours tend to disseminate early, yet metastases often take years to maifest. What determines when and where they form? @alpcorreia discusses the site specific immune barriers to metastasis in this perspective
Tweet media one
1
48
213
@NatRevImmunol
Nature Rev Immunol
3 years
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Tweet media one
1
56
212
@NatRevImmunol
Nature Rev Immunol
3 years
Is IL-6 a key cytokine target for therapy in COVID-19?
Tweet media one
2
83
216
@NatRevImmunol
Nature Rev Immunol
4 years
How transcription factors drive choice of the T cell fate
Tweet media one
0
66
211
@NatRevImmunol
Nature Rev Immunol
3 years
Our October 2021 issue marks 20 years of Nature Reviews Immunology - see our special anniversary collection:
Tweet media one
6
92
214
@NatRevImmunol
Nature Rev Immunol
9 months
Therapeutic induction of antigen-specific immune tolerance
Tweet media one
2
56
190
@NatRevImmunol
Nature Rev Immunol
2 years
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Tweet media one
7
75
207
@NatRevImmunol
Nature Rev Immunol
2 years
Understanding COVID-19-associated coagulopathy
Tweet media one
7
105
213
@NatRevImmunol
Nature Rev Immunol
2 years
The link between circulating follicular helper T cells and autoimmunity
Tweet media one
2
56
210
@NatRevImmunol
Nature Rev Immunol
4 years
Sex differences in immune responses in COVID-19
2
90
208
@NatRevImmunol
Nature Rev Immunol
4 years
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
Tweet media one
1
54
206
@NatRevImmunol
Nature Rev Immunol
3 years
The state of complement in COVID-19
Tweet media one
3
75
208
@NatRevImmunol
Nature Rev Immunol
3 years
Immune and non-immune functions of adipose tissue leukocytes
Tweet media one
3
42
205
@NatRevImmunol
Nature Rev Immunol
2 years
Tumour immunotherapy: lessons from predator–prey theory
Tweet media one
2
65
208
@NatRevImmunol
Nature Rev Immunol
5 years
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Tweet media one
1
81
202
@NatRevImmunol
Nature Rev Immunol
9 months
Brain regulatory T cells
Tweet media one
0
61
195
@NatRevImmunol
Nature Rev Immunol
1 year
Cell death by phagocytosis
Tweet media one
1
51
194
@NatRevImmunol
Nature Rev Immunol
4 years
Diversity and dynamism of IgA−microbiota interactions
Tweet media one
1
55
190
@NatRevImmunol
Nature Rev Immunol
4 years
See the new Comment from Schett et al. on COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
Tweet media one
1
118
187
@NatRevImmunol
Nature Rev Immunol
3 years
Immune-based therapies in cardiovascular and metabolic diseases: past, present and future
Tweet media one
1
55
188
@NatRevImmunol
Nature Rev Immunol
3 years
Tissue regulatory T cells: regulatory chameleons
Tweet media one
1
59
188
@NatRevImmunol
Nature Rev Immunol
5 years
B cells, plasma cells and antibody repertoires in the tumour microenvironment
Tweet media one
1
79
182
@NatRevImmunol
Nature Rev Immunol
4 years
Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge
Tweet media one
1
72
184
@NatRevImmunol
Nature Rev Immunol
6 months
Bone marrow inflammation in haematological malignancies
Tweet media one
3
67
186
@NatRevImmunol
Nature Rev Immunol
8 months
Integrated organ immunity: a path to a universal vaccine
Tweet media one
0
60
185
@NatRevImmunol
Nature Rev Immunol
3 years
SARS-CoV-2 and HIV-1 — a tale of two vaccines
Tweet media one
1
56
177
@NatRevImmunol
Nature Rev Immunol
9 months
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Tweet media one
1
57
171
@NatRevImmunol
Nature Rev Immunol
7 months
The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases
Tweet media one
1
61
180
@NatRevImmunol
Nature Rev Immunol
5 months
NEW Review of the molecular mechanisms by which short-chain fatty acids - butyrate, propionate and acetate - link diet, microbiota and immunity by @lizziemannlab @YingKaLam & Holm Uhlig
Tweet media one
0
52
179
@NatRevImmunol
Nature Rev Immunol
6 years
New #Review on CD4+ T cell help in cancer, discussing the molecular nature of help signals and how they can be harnessed to improve cancer immunotherapy.
Tweet media one
0
93
178